A 32-year-old woman with mild intermittent asthma uses her salbutamol inhaler a few times each week, especially during viral infections. She has no hospitalisations but reports waking with wheeze once weekly. Spirometry confirms reversible airflow obstruction. According to updated Canadian asthma guidance, which regimen is most appropriate to reduce exacerbation risk?